Subject: | |
From: | |
Reply To: | |
Date: | Mon, 29 Mar 2021 12:01:58 +0200 |
Content-Type: | text/plain |
Parts/Attachments: |
|
|
>
> That's almost exactly double the dose, despite the formulation differences
> in the Api-Bioxal
>
> Anyone have any ideas as to the significant difference in suggested dose
> between US and UK/EU?
The reply to that question from the producing company:
"The products to which it refers are two conceptually different products
although they bear the same name and the same raw material.
The reason for the difference in composition and method of use is due to
the fact that in America we are sub-contractors. The holder of the product
registration is the USDA, as registrant they have chosen, on the basis of
their know-how, the composition and method of administration of the product.
In Europe is our company that is the holder of the marketing authorization.
The composition and methods of use of the product are based on our
experience, on the experience of Italian beekeepers."
***********************************************
The BEE-L mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html
|
|
|